U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Dacarbazine Injection
Status: Currently in Shortage
»Date first posted: 10/20/2021
»Therapeutic Categories: Oncology

Expand all

Fresenius Kabi USA, LLC (Revised 07/16/2024)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 10 mg/1 mL (NDC 63323-127-10) Unavailable Backordered. Next release July 2024.; Check wholesaler inventory Demand increase for the drug
Injection, 10 mg/1 mL (NDC 63323-128-20) Available Check wholesalers for inventory

Hikma Pharmaceuticals USA, Inc. (Reverified 05/23/2024)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Dacarbazine for Injection, USP, Injection, 200 mg per Vial (NDC 0143-9245-10) Unavailable Additional lots will be available in the June 2024 timeframe. Product will be made available as it is released. Demand increase for the drug

Meitheal Pharmaceuticals, Inc. (New 07/22/2024)

Company Contact Information:
844-824-8426

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 200 mg/20 mL (NDC 71288-174-21) Available New launch
Back to Top